Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors.

Yan M, Myung SJ, Fink SP, Lawrence E, Lutterbaugh J, Yang P, Zhou X, Liu D, Rerko RM, Willis J, Dawson D, Tai HH, Barnholtz-Sloan JS, Newman RA, Bertagnolli MM, Markowitz SD.

Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9409-13. doi: 10.1073/pnas.0902367106. Epub 2009 May 22.

2.

15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis.

Myung SJ, Rerko RM, Yan M, Platzer P, Guda K, Dotson A, Lawrence E, Dannenberg AJ, Lovgren AK, Luo G, Pretlow TP, Newman RA, Willis J, Dawson D, Markowitz SD.

Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):12098-102. Epub 2006 Jul 31.

3.

15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers.

Yan M, Rerko RM, Platzer P, Dawson D, Willis J, Tong M, Lawrence E, Lutterbaugh J, Lu S, Willson JK, Luo G, Hensold J, Tai HH, Wilson K, Markowitz SD.

Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17468-73. Epub 2004 Dec 1.

4.

SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers.

Li H, Myeroff L, Smiraglia D, Romero MF, Pretlow TP, Kasturi L, Lutterbaugh J, Rerko RM, Casey G, Issa JP, Willis J, Willson JK, Plass C, Markowitz SD.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8412-7. Epub 2003 Jun 26.

5.

PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.

Brunschwig EB, Wilson K, Mack D, Dawson D, Lawrence E, Willson JK, Lu S, Nosrati A, Rerko RM, Swinler S, Beard L, Lutterbaugh JD, Willis J, Platzer P, Markowitz S.

Cancer Res. 2003 Apr 1;63(7):1568-75.

7.
8.
9.

In vivo production and function of IL-12 p40 homodimers.

Heinzel FP, Hujer AM, Ahmed FN, Rerko RM.

J Immunol. 1997 May 1;158(9):4381-8.

PMID:
9127002
10.

IFN-gamma-independent production of IL-12 during murine endotoxemia.

Heinzel FP, Rerko RM, Ahmed F, Hujer AM.

J Immunol. 1996 Nov 15;157(10):4521-8.

PMID:
8906830
11.

Immunoregulation of murine leishmaniasis by interleukin-12.

Heinzel FP, Ahmed F, Hujer AM, Rerko RM.

Res Immunol. 1995 Sep-Oct;146(7-8):575-81. Review.

PMID:
8839164
12.
13.

Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon.

Heinzel FP, Rerko RM, Ling P, Hakimi J, Schoenhaut DS.

Infect Immun. 1994 Oct;62(10):4244-9.

14.

IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts.

Heinzel FP, Rerko RM, Hatam F, Locksley RM.

J Immunol. 1993 May 1;150(9):3924-31.

PMID:
8473741
15.

Recombinant interleukin 12 cures mice infected with Leishmania major.

Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK.

J Exp Med. 1993 May 1;177(5):1505-9.

16.

Photofrin II photosensitization is mutagenic at the tk locus in mouse L5178Y cells.

Rerko RM, Clay ME, Antunez AR, Oleinick NL, Evans HH.

Photochem Photobiol. 1992 Jan;55(1):75-80.

PMID:
1534908
17.

Cytotoxic and mutagenic effects of the photodynamic action of chloroaluminum phthalocyanine and visible light in L5178Y cells.

Evans HH, Rerko RM, Mencl J, Clay ME, Antunez AR, Oleinick NL.

Photochem Photobiol. 1989 Jan;49(1):43-7. No abstract available.

PMID:
2717667

Supplemental Content

Loading ...
Support Center